Drug gives lung cancer patients four extra months

Most lung cancer patients survived four months longer on an immunotherapy drug than those treated with chemotherapy, according to trial results published Monday.

Drug - Daily NationImportantly, they also experienced fewer side-effects, researchers reported in The Lancet medical journal.

Patients with non-small-cell lung…

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button